AIMS: To investigate the relationships between tobacco dependence, biomarkers of nicotine and carcinogen exposure and biomarkers of nicotine and carcinogen exposure per cigarette in back and white smokers. DESIGN, SETTING AND PARTICIPANTS: A total of 204 healthy black (n = 69) and white (n = 135) smokers were enrolled into two clinical studies. MEASUREMENT: Nicotine equivalents (nicotine and its metabolites), 4-(methylnitrosamino)-1-(3)pyridyl-1-butanol (NNAL) and polycyclic aromatic hydrocarbon (PAH) metabolites were measured in urine. The Fagerström Test for Nicotine Dependence (FTND) and time to first cigarette (TFC) measured tobacco dependence. FINDINGS: Average TFC and FTND for blacks and whites were not significantly different. Urine NNAL and nicotine equivalents increased with increasing FTND in whites but did not increase in blacks (race × FTND interaction, both P < 0.031). The interaction term was not significant for PAHs. An inverse relationship was seen between FTND and nicotine equivalents, NNAL and PAH metabolites per cigarette in blacks but remained flat in whites (race × FTND interaction, all P ≤ 0.039). Regardless of dependence (low dependence, TFC >15 minutes; high dependence, TFC ≤15 minutes), FTND and TFC were not correlated significantly with urine nicotine equivalents and carcinogen exposure in blacks. We found moderate correlations between FTND and TFC and nicotine equivalents and carcinogen exposure among whites of low dependence and non-significant correlations among whites of high dependence. CONCLUSION: In the United States, tobacco dependence measures were related linearly to nicotine intake and carcinogen exposure in white but not in black smokers. The relationship between dependence measures and tobacco biomarkers in black smokers regardless of level of dependence resembled highly dependent white smokers.
AIMS: To investigate the relationships between tobacco dependence, biomarkers of nicotine and carcinogen exposure and biomarkers of nicotine and carcinogen exposure per cigarette in back and white smokers. DESIGN, SETTING AND PARTICIPANTS: A total of 204 healthy black (n = 69) and white (n = 135) smokers were enrolled into two clinical studies. MEASUREMENT: Nicotine equivalents (nicotine and its metabolites), 4-(methylnitrosamino)-1-(3)pyridyl-1-butanol (NNAL) and polycyclic aromatic hydrocarbon (PAH) metabolites were measured in urine. The Fagerström Test for Nicotine Dependence (FTND) and time to first cigarette (TFC) measured tobacco dependence. FINDINGS: Average TFC and FTND for blacks and whites were not significantly different. Urine NNAL and nicotine equivalents increased with increasing FTND in whites but did not increase in blacks (race × FTND interaction, both P < 0.031). The interaction term was not significant for PAHs. An inverse relationship was seen between FTND and nicotine equivalents, NNAL and PAH metabolites per cigarette in blacks but remained flat in whites (race × FTND interaction, all P ≤ 0.039). Regardless of dependence (low dependence, TFC >15 minutes; high dependence, TFC ≤15 minutes), FTND and TFC were not correlated significantly with urine nicotine equivalents and carcinogen exposure in blacks. We found moderate correlations between FTND and TFC and nicotine equivalents and carcinogen exposure among whites of low dependence and non-significant correlations among whites of high dependence. CONCLUSION: In the United States, tobacco dependence measures were related linearly to nicotine intake and carcinogen exposure in white but not in black smokers. The relationship between dependence measures and tobacco biomarkers in black smokers regardless of level of dependence resembled highly dependent white smokers.
Authors: Neal L Benowitz; Gary E Swan; Peyton Jacob; Christina N Lessov-Schlaggar; Rachel F Tyndale Journal: Clin Pharmacol Ther Date: 2006-11 Impact factor: 6.875
Authors: Christopher A Haiman; Daniel O Stram; Lynne R Wilkens; Malcolm C Pike; Laurence N Kolonel; Brian E Henderson; Loïc Le Marchand Journal: N Engl J Med Date: 2006-01-26 Impact factor: 91.245
Authors: Peyton Jacob; Christopher Havel; Do-Hoon Lee; Lisa Yu; Mark D Eisner; Neal L Benowitz Journal: Anal Chem Date: 2008-10-08 Impact factor: 6.986
Authors: Loïc Le Marchand; Kiersten S Derby; Sharon E Murphy; Stephen S Hecht; Dorothy Hatsukami; Steven G Carmella; Maarit Tiirikainen; Hansong Wang Journal: Cancer Res Date: 2008-11-15 Impact factor: 12.701
Authors: Dana M Carroll; Shannon Cigan; Joshua Ikuemonisan; Taylor Hammonds; Irina Stepanov; Gideon St Helen; Neal Benowitz; Dorothy K Hatsukami Journal: Nicotine Tob Res Date: 2020-10-29 Impact factor: 4.244
Authors: Robert A Schnoll; Tony P George; Larry Hawk; Paul Cinciripini; Paul Wileyto; Rachel F Tyndale Journal: Psychopharmacology (Berl) Date: 2014-01-09 Impact factor: 4.530
Authors: Nicole L Nollen; Matthew S Mayo; Lauren Clark; Lisa Sanderson Cox; Samir S Khariwala; Kim Pulvers; Neal L Benowitz; Jasjit S Ahluwalia Journal: Drug Alcohol Depend Date: 2017-08-16 Impact factor: 4.492
Authors: Meghan J Chenoweth; Andy Z X Zhu; Lisa Sanderson Cox; Jasjit S Ahluwalia; Neal L Benowitz; Rachel F Tyndale Journal: Pharmacogenet Genomics Date: 2014-03 Impact factor: 2.089
Authors: Neal L Benowitz; Gideon St Helen; Natalie Nardone; Lisa Sanderson Cox; Peyton Jacob Journal: Nicotine Tob Res Date: 2020-02-06 Impact factor: 4.244
Authors: Meghan J Chenoweth; Jennifer J Ware; Andy Z X Zhu; Christopher B Cole; Lisa Sanderson Cox; Nikki Nollen; Jasjit S Ahluwalia; Neal L Benowitz; Robert A Schnoll; Larry W Hawk; Paul M Cinciripini; Tony P George; Caryn Lerman; Joanne Knight; Rachel F Tyndale Journal: Addiction Date: 2017-11-02 Impact factor: 6.526
Authors: Kathryn C Ross; Delia A Dempsey; Gideon St Helen; Kevin Delucchi; Neal L Benowitz Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-03-30 Impact factor: 4.254